These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 1942539)
1. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis. Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247 [TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele. Jaquet K; Kreipe H; Felgner J; Boultwood J; Parwaresch MR Leukemia; 1993 Apr; 7(4):650-2. PubMed ID: 8464244 [No Abstract] [Full Text] [Related]
4. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome]. Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539 [TBL] [Abstract][Full Text] [Related]
5. Deletions of chromosome 5 in malignant myeloid disorders. Le Beau MM Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109 [TBL] [Abstract][Full Text] [Related]
6. Genetic lesions in preleukemia. Carter G; Ridge S; Padua RA Crit Rev Oncog; 1992; 3(4):339-64. PubMed ID: 1420444 [TBL] [Abstract][Full Text] [Related]
7. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464 [TBL] [Abstract][Full Text] [Related]
9. The process of leukemogenesis. Irons RD; Stillman WS Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1239-46. PubMed ID: 9118899 [TBL] [Abstract][Full Text] [Related]